Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.16 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.13 | 0.4 |